Invest In Biomed Program

Invest In Biomed 2025 is launched!

This unique program helps selected startups to structure their fundraising and meet specialized investors in their sector.

Benefits for Invest In Biomed 2025 startups

  • Adapt their communications to convince investors
  • Get personalized feedback on the content and form of their pitch deck from experienced healthcare fundraising professionals
  • Receive coaching on their oral performance
  • Present their project to a panel of investors specialized in their field
  • Establish or consolidate links with these investors and obtain their qualitative feedback on their project
  •  

 

 

The Invest In Biomed program

6 group or individual workshops from March to June 2025, led by healthcare and fundraising experts

Flash review of your project

A 360° analysis of your project, based on a deck review and two interviews

Experts involved: Eurobiomed's experts

Understand investors' expectations and their modalities of investments

Experts involved: healthcare VCs

Work on your equity story and deck

Experts involved: healthcare fundraising experts

Refine your oral presentation

Experts involved: communications consultant

Health investment day

Pitch presentations by project leaders and investors
BtoB networking session

Preparing the next steps of your fundraising

Investor meetings' debriefs
Preparation of next steps in the fundraising process

Experts involved: Eurobiomed's experts

Read the testimonials of 4 startups supported by Invest In Biomed

A look back at 2024 

Class of 2024 healthcare fundraising experts

  • Sofia ARNAL - Associate AdBio Partners, trained pharmacist
  • Sophie BRAUN - Health consultant In Extenso Croissance
  • Karine CHORRO - Phost'In Therapeutics, CEO and co-founder, ex deputy director Genepep
  • Stéphane DEBONO - Former Deputy CEO and VP HalioDx
  • Vincent FERT - Partner Turenne Groupe, former CEO/President HalioDx
  • Pierre HORNUS - CEO/Co-founder Semeia
  • Francine LANCELEUR BRENNING - Qualitalents Director, former General Manager/BD MediHandTrace
  • Laure Hélène MERCIER - LH Mercier Conseil, consultant in fund raising, IPO, ex CFO Innate Pharma
  • Claire NAUSSAC - Operating partner Truffle Capital
  • Claire VERSCHELDE - ICOSA, Co-founding partner, IP specialist
  • Grégory VOISIN - CEO and founder of ToxiPlan

 

Investors in the Class of 2024

Program partners

Invest In Biomed bénéficie du soutien de la Région Occitanie et l’Union Européenne via le fonds FEDER.

Our public sponsors

 

For more information

Contact us!


No results found.